ALOX15B and prostate carcinoma: Contrastingly, DHT treatment of breast carcinoma BT474 cells increased ALOX15B expression (Vasiliou et al., 2022), whereas in prostate carcinoma LNCaP cells, transfection with a plasmid containing the ALOX15B promoter remained unresponsive to androgen treatment (Tang et al., 2004).